舒张性心力衰竭诊断和治疗专家共识

2019-12-01 中国心血管相关专家小组(统称) 临床心血管病杂志.2020.36(1):1-10.

心力衰竭(心衰)是一种异质性很强的复杂临床综合征,根据左室射血分数对心衰进行分类简便易行,但存在局限性。收缩性心衰(SHF)与舒张性心衰(DHF)病理生理机制不同,SHF应用神经激素拮抗剂治疗显著获益,DHF病理生理机制涉及系统性炎症、代谢紊乱、心外膜脂肪组织堆积、心肌微血管功能障碍、心肌纤维化等,DHF的有效治疗尚未明确。DHF诊断建议采用超声心动图提出的心功能诊断标准。目前DHF治疗策略包括对

中文标题:

舒张性心力衰竭诊断和治疗专家共识

发布日期:

2019-12-01

简要介绍:

心力衰竭(心衰)是一种异质性很强的复杂临床综合征,根据左室射血分数对心衰进行分类简便易行,但存在局限性。收缩性心衰(SHF)与舒张性心衰(DHF)病理生理机制不同,SHF应用神经激素拮抗剂治疗显著获益,DHF病理生理机制涉及系统性炎症、代谢紊乱、心外膜脂肪组织堆积、心肌微血管功能障碍、心肌纤维化等,DHF的有效治疗尚未明确。DHF诊断建议采用超声心动图提出的心功能诊断标准。目前DHF治疗策略包括对症治疗、探索性抗炎症和抗代谢药物治疗。为了减少心衰再住院率,神经激素拮抗剂适用于大多数SHF合并DHF患者的治疗。

 

拓展指南:心力衰竭相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=舒张性心力衰竭诊断和治疗专家共识)] GetToolGuiderByIdResponse(projectId=1, id=5df221c00183839d, title=舒张性心力衰竭诊断和治疗专家共识, enTitle=, guiderFrom=临床心血管病杂志.2020.36(1):1-10., authorId=null, author=, summary=心力衰竭(心衰)是一种异质性很强的复杂临床综合征,根据左室射血分数对心衰进行分类简便易行,但存在局限性。收缩性心衰(SHF)与舒张性心衰(DHF)病理生理机制不同,SHF应用神经激素拮抗剂治疗显著获益,DHF病理生理机制涉及系统性炎症、代谢紊乱、心外膜脂肪组织堆积、心肌微血管功能障碍、心肌纤维化等,DHF的有效治疗尚未明确。DHF诊断建议采用超声心动图提出的心功能诊断标准。目前DHF治疗策略包括对, cover=, journalId=null, articlesId=null, associationId=306, associationName=中国心血管相关专家小组(统称), associationIntro=本制定者非特指某个专家小组,为统称。, copyright=0, guiderPublishedTime=Sun Dec 01 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<P>心力衰竭(心衰)是一种异质性很强的复杂临床综合征,根据左室射血分数对心衰进行分类简便易行,但存在局限性。收缩性心衰(SHF)与舒张性心衰(DHF)病理生理机制不同,SHF应用神经激素拮抗剂治疗显著获益,DHF病理生理机制涉及系统性炎症、代谢紊乱、心外膜脂肪组织堆积、心肌微血管功能障碍、心肌纤维化等,DHF的有效治疗尚未明确。DHF诊断建议采用超声心动图提出的心功能诊断标准。目前DHF治疗策略包括对症治疗、探索性抗炎症和抗代谢药物治疗。为了减少心衰再住院率,神经激素拮抗剂适用于大多数SHF合并DHF患者的治疗。 </P> <P> </P>拓展指南:<strong>与<font color=red>心力衰竭</font>相关指南:</strong><br><ul><li><a href="https://www.medsci.cn/guideline/show_article.do?id=f194b1c00183252a" title="慢性心力衰竭基层诊疗指南(实践版·2019)" target=_blank>慢性心力衰竭基层诊疗指南(实践版·2019)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=0530b1c001832a38" title="慢性心力衰竭基层诊疗指南(2019年)" target=_blank>慢性心力衰竭基层诊疗指南(2019年)</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=d01661c00181a1e1" title="急性心力衰竭治疗药物临床试验技术指导原则" target=_blank>急性心力衰竭治疗药物临床试验技术指导原则</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=56fe31c0018131eb" title="中药新药用于慢性心力衰竭临床研究技术指导原则" target=_blank>中药新药用于慢性心力衰竭临床研究技术指导原则</a></li> <li><a href="https://www.medsci.cn/guideline/show_article.do?id=139ff1c00180e6bd" title="2019 专家共识:应用正性肌力药治疗急性和晚期心力衰竭" target=_blank>2019 专家共识:应用正性肌力药治疗急性和晚期心力衰竭</a></li> 更多信息请点击:<a href="https://www.medsci.cn/guideline/list.do?q=%E5%BF%83%E5%8A%9B%E8%A1%B0%E7%AB%AD" target=_blank>有关心力衰竭更多指南</a></ul>, tagList=[TagDto(tagId=97875, tagName=舒张性心力衰竭)], categoryList=[CategoryDto(categoryId=2, categoryName=心血管, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=3, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8983, appHits=838, showAppHits=63, pcHits=6133, showPcHits=3588, likes=145, shares=40, comments=4, approvalStatus=1, publishedTime=Fri Dec 13 00:26:41 CST 2019, publishedTimeString=2019-12-01, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Fri Dec 13 00:26:41 CST 2019, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 00:07:21 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=舒张性心力衰竭诊断和治疗专家共识)])
舒张性心力衰竭诊断和治疗专家共识
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1064455, encodeId=d35b10644559e, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Wed Oct 27 20:02:29 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009263, encodeId=be3a100926363, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be315562142, createdName=swordman101, createdTime=Wed Aug 18 21:32:17 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978532, encodeId=b55b9e853250, content=好好学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/b477d71ea8b7497ba2e055d92a2c9cb3/1cf0d5b65b244df4989936af9d596ecb.jpg, createdBy=e7c25183703, createdName=14700d17m84暂无昵称, createdTime=Thu Jul 01 10:04:49 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978531, encodeId=f9449e853196, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/b477d71ea8b7497ba2e055d92a2c9cb3/1cf0d5b65b244df4989936af9d596ecb.jpg, createdBy=e7c25183703, createdName=14700d17m84暂无昵称, createdTime=Thu Jul 01 10:04:24 CST 2021, time=2021-07-01, status=1, ipAttribution=)]
    2021-10-27 1e1366a1m07(暂无匿称)

    学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1064455, encodeId=d35b10644559e, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Wed Oct 27 20:02:29 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009263, encodeId=be3a100926363, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be315562142, createdName=swordman101, createdTime=Wed Aug 18 21:32:17 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978532, encodeId=b55b9e853250, content=好好学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/b477d71ea8b7497ba2e055d92a2c9cb3/1cf0d5b65b244df4989936af9d596ecb.jpg, createdBy=e7c25183703, createdName=14700d17m84暂无昵称, createdTime=Thu Jul 01 10:04:49 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978531, encodeId=f9449e853196, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/b477d71ea8b7497ba2e055d92a2c9cb3/1cf0d5b65b244df4989936af9d596ecb.jpg, createdBy=e7c25183703, createdName=14700d17m84暂无昵称, createdTime=Thu Jul 01 10:04:24 CST 2021, time=2021-07-01, status=1, ipAttribution=)]
    2021-08-18 swordman101

    学习

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1064455, encodeId=d35b10644559e, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Wed Oct 27 20:02:29 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009263, encodeId=be3a100926363, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be315562142, createdName=swordman101, createdTime=Wed Aug 18 21:32:17 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978532, encodeId=b55b9e853250, content=好好学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/b477d71ea8b7497ba2e055d92a2c9cb3/1cf0d5b65b244df4989936af9d596ecb.jpg, createdBy=e7c25183703, createdName=14700d17m84暂无昵称, createdTime=Thu Jul 01 10:04:49 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978531, encodeId=f9449e853196, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/b477d71ea8b7497ba2e055d92a2c9cb3/1cf0d5b65b244df4989936af9d596ecb.jpg, createdBy=e7c25183703, createdName=14700d17m84暂无昵称, createdTime=Thu Jul 01 10:04:24 CST 2021, time=2021-07-01, status=1, ipAttribution=)]
    2021-07-01 14700d17m84暂无昵称

    好好学习!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1064455, encodeId=d35b10644559e, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ef2c1960942, createdName=1e1366a1m07(暂无匿称), createdTime=Wed Oct 27 20:02:29 CST 2021, time=2021-10-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1009263, encodeId=be3a100926363, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=81, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=be315562142, createdName=swordman101, createdTime=Wed Aug 18 21:32:17 CST 2021, time=2021-08-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978532, encodeId=b55b9e853250, content=好好学习!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/b477d71ea8b7497ba2e055d92a2c9cb3/1cf0d5b65b244df4989936af9d596ecb.jpg, createdBy=e7c25183703, createdName=14700d17m84暂无昵称, createdTime=Thu Jul 01 10:04:49 CST 2021, time=2021-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=978531, encodeId=f9449e853196, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210701/b477d71ea8b7497ba2e055d92a2c9cb3/1cf0d5b65b244df4989936af9d596ecb.jpg, createdBy=e7c25183703, createdName=14700d17m84暂无昵称, createdTime=Thu Jul 01 10:04:24 CST 2021, time=2021-07-01, status=1, ipAttribution=)]
    2021-07-01 14700d17m84暂无昵称

    学习

    0